1,018
Views
5
CrossRef citations to date
0
Altmetric
Health Technology

Relevance of barriers and facilitators in the use of health technology assessment in Colombia

, , , & ORCID Icon
Pages 510-517 | Received 20 Nov 2017, Accepted 01 Mar 2018, Published online: 23 Mar 2018

References

  • Goodman CS. HTA 101: Introduction to Health Technology Assessment. Bethesda, MD: National Library of Medicine (US); 2014
  • Sorenson C, Drummond M, Khan BB. Michael; Khan, Beena Bhuiyan. Medical technology as a key driver of rising health expenditure: disentangling the relationship. ClinicoEconomics and Outcomes Research 2013;5:223-234
  • Castro Jaramillo HE, Osorio-Cuevas D, Moreno-Mattar O. Emergenece of “Drivers” for the implementation of Health Technology Assessment. Int J Technol Assess Health Care 2016;32:300-306
  • WHO. Health technology assessment. who.int [Internet]. WHO; [cited 2017 Oct 10] Available from: http://www.who.int/medical_devices/assessment/en/
  • Banta D. The development of health technology assessment. Health Policy 2003;63:121-132
  • Pichon Riviere A, Augustovski F, García Martí S, et al. Transferability of health technology assement reports in Latin America: an exploratory survey of researchers and decision makers. Int J Technol Assess Health Care 2012;28:180-6
  • Glassman A, Chalkidou K, Giedion U, et al. Priority-setting institutions in health – recommendations from a center for global development working group. Global Heart 2012;7:13-34
  • Augustovski F, Alcaracz A, Caporale J, et al. Institutionalizing health technology assessment for priority setting and health policy in Latin America: from regional endeavors to national experiences. Expert Rev Pharmacoeconom Outcomes Res 2015;15:9-12
  • Castro Jaramillo HE. Advancing HTA in Latin America: the policy process of setting up an HTA agency in Colombia. Global Policy 2017;8:97-102
  • Vargas-Zea N, Castro H, Rodríguez-Páez F, et al. Colombian health system on its way to improve allocation efficiency – transition from a health sector reform to the settlement of an HTA agency. Value Health Region Iss 2012;1:218-222
  • Neumann PJ. Why dont Americans use cost-effectiveness analysis? Am J Manag Care 2004;10:308-12
  • Cheung KL, Evers S, de Fries H, et al. Most important barriers and facilitators regarding the use of health technology assessment. Int J Technol Assess Health Care 2017;33:183-191
  • Marley AAJ, Louviere J. Some probabilistic models of best, worst, and best–worst choices. J Math Psychol 2005;49:464-480
  • Whitty JA, Walker R, Golenko X, et al. A think aloud study comparing the validity and acceptability of discrete choice and best worst scaling methods. PLoS One 2014;9:1-9
  • Sawtooth-Software. Identifying ‘bad’ respondents: Fit statistic and identifying random responders. Sawtoothsoftware.com [Internet]. Sawtoothsoftware; [cited 2017 Sep 15]. Available from: https://www.sawtoothsoftware.com/help/lighthouse-studio/manual/hid_web_maxdiff_badrespondents.html
  • Cheung KL, Wijnen BFM, Hollin IL, et al. Using best-worst scaling to investigate preferences in health care. PharmacoEconomics 2016;34:1195-209
  • Kruschke JK, Vanpaemel W. Bayesian estimation in hierarchical models. The Oxford Handbook of Computational and Mathematical Psychology. Oxford: Oxford University Press; 2015. p 279-99
  • Pichon Riviere A, Augustovski F, Rubistein A, et al. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Int J Technol Assess Health Care 2010;26:421-7
  • Banta D, Jonsson E. History of HTA: introduction. Int J Technol Assess Health Care 2009;25:1-6
  • Banta D. Health technology assessment in Latin America and the Caribbean. Int J Technol Assess Health Care 2009;25:253-254
  • Feig C, Hiligsmann M, Evers S, et al. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria. Expert Rev Pharmacoeconom Outcomes Res 2017;8:223-232

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.